Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where is Bambi? He is a big supporter of the Doc, maybe he has been off reading one of the Doc's books. He hasn't been around for a while spreading his falsehoods. But what about his resume and all his investor experience. What about all the conversations with HR? This is and has been circling the drain for a long time now. I was hoping for another BS PR so I can get rid of my remaining shares. Oh well!
Seems the ‘bashers’were on to something
But but but....Mr. Sloppy says soon
...like he has for years. 😂 😢
Peeps finally realizing something isn't right.......it's only been pointed out dozens of times.
Just like Otiko is as a novelist.
https://www.amazon.com/stores/Christopher-Otiko/author/B00N1B4AZ6
https://www.amazon.com/stores/author/B00N1B4AZ6/about
He's playing around writing books now and doesn't care about the company. Wonder where that $700k personal loan went to?
Oof. Almost 900k dumped at .00511. This thing is toast
I think someone is full of shit both here on this board and with IR and Dr O……
the doc never replies so something must be going on! and why would he get all the filings up to date and spend that money and time if something was going on?
Look I get it but you have to admit it is possible he is saying the truth. There was another dude in here whom the friend of his friend gave him accurate intel over the pink update fillings. That dude genuinely was getting contact with the inside. Maybe this guy really got replies. You never know! I want him to be right
The product is real and you know it. I think it is a matter of time for this to fly high enough to let a few of us GTFO
You forgot the $700K and previous forgiven loan he got. Did he smoke it ? Go go bars? Gambling ?? Where did the money go and we will get it back?
That’s his due date, he will do something silly like ORCA. He will get sooo high… Hopefully he doesn’t end up in the E.R. Viva VDRM
I sent them your questions. We are all very interested to read their responses.
excelsiorvision You expect answers from Salsaman?
What happened to the international recognition? You know, all those huge distribution deals to Egypt, India, etc where they were supposed to be shipping to back in March? VA deals? Large HMO deals? Dubai? Nupelo?
It has been frustrating to say the least. We know how great the product is and I believe it will get the national recognition it deserves. We are hoping to have some good news out soon. Please stay tuned,
Rich
Thanks for being a loyal investor, there will be positive news coming very soon.
Dr.Chris Otiko
Two questions- First I thought you mentioned that your emails got rejected?
Second - would you be as so kind to share the actual responses removing your email name of course?
Chris@viaderma.com
richardinza@gmail.com
I received 2 replies. One from Rich Inza and one from the Dr. himself. Basically said, news soon, actually very soon ! Viaderm will get the national recognition it deserves .
I believe the following 3 emails all work:
Ir@viaderma.com
Richardinza@gmail.com
Garrett@viaderma.com
Good luck getting in touch with them. I believe they have all gone into hiding now that their is this “odor” of malfeasance and mismanagement of fiduciary duties by Dr Otiko by taking the loan of which no repayment details has been provided in the Quarterly…..
Slops… why did you post this date?
I sent an email to all of the addresses listed. They all got rejected. They were all undeliverable. I called the number provided and a nice lady picked up. I asked a few questions and she provided me with the info email address. I informed her that address rejected my past emails. She then took my information and stated someone would get in contact with me .
It is a gamble, it can happen. The question is, will it happen? Naah
We're all hoping it hits 20 cents some day, but very few of us actually believe it will ever get there.
I would love to be surprised.
There won't be any backlash, at least not in this one. Nothing illegal has been done in here and nothing wrongful that can be proven in court, well, other than some virgin investor got molested while in their sleep by a Nigerian Vampire..... It is just bad business, nothing else. Don't you believe me? Check HMBL LMAOOOOOOOOOOOOOOOOOOOOOOOOOOOOO \
Perfect example is HMBL, Period...
Bought 500 k today, hoping to see 20 cents one day, never doubt on OTIKO
I am so sick of OTIKO, Otiko bend down and see the results
They really suck now and have for awhile. Don't even know why they have an IR or give Rich any shares in the company. The guy barely responds to anyone it seems or just gives BS answers or won't answer direct questions.
You can only push and screw over the shareholders for so long until theres a major backlash. IMO it's coming and from reading a lot of these posts, federal complaints and lawsuits against otiko and the business will be picking up.
Their only saving grace will be coming out with substantial news developments that can be backed up with proof and revenue on the books.
Good luck with that. They will probably come off as though “they deserved it” like all the free shares as well.
Not like us shareholders have been supporting the company or anything from day one. This guy and the IR guy to me come off as pompous assholes as far as what people have posted from their communications through the years.
Don’t worry, we’re not there yet. If history repeats in market, 0.005 is the floor, we been there back when he made up the Dubai fiasco. After that it bounced. Just keep adding the dip to average down !!!!
Viva our Nigerian Vampire
Time to get some answers from all of them.
These emails have been floating around.
ViaDerma IR
ir@viaderma.com
richardinza@gmail.com
info@viaderma.com
support@viaderma.com
Can also try these standard email contacts and linkedins
CEO - Chris Otiko
https://www.linkedin.com/in/chris-otiko-5b7873141
cotiko@viaderma.com
chris.otiko@viaderma.com
chris@viaderma.com
President - Garrett Adams
https://www.linkedin.com/in/garrettradams
gadams@viaderma.com
garrett.adams@viaderma.com
garrett@viaderma.com
Hey doctor get the rag out of your ass give the share holders something to be proud of your just dead weight at this point
I’m leaning that way also but trashing our investment serves no good purpose to anyone. You are correct the Dr. has not been truthful to his investors…let’s hope he changes his ways 😀
Agree - IF* I were to do that it would be generally speaking. I wouldn’t mention the clinic.
I mean, generally speaking the Dr. is a lying scumbag lol
Fasctrack I get it. Best thing 2 do is nothing. Do U think I am happy? No one is so just
wait for the next run & bail. I honestly believe it will be soon GLTA
7 years ya should have made some money. I have also and bought from .0012 and up made money on couple of runs to .07 so it has not been alll bad ..let’s hope he does the right thing and move the company along …
So what do you suggest we do? Would you have us be sheep and drink the Kool Aid? I have been invested here for 7 years....yeah I know shame on me for being an idiot and buying into his BS. At what point do we say enough with the BS? 7 years of BS PRs and not one announcement has come to fruition in any material sense. Name one...I dare you. Do you think that is reasonable? Do you think that is acceptable performance for a CEO of a publically held company? I think he has very much exceeded his authority by transferring the distribution rights to his privately owned company, by entering into a lucrative distribution contract with his privately owned company, and by awarding himself 100,000,000 shares. I'd vote to fire him. I wouldn't hire him to run the local McDonalds drive through line. I'd sell but I am underwater on this dog with fleas. You need to wake up; the thought or hope of him pulling a rabbit out of his hat at this point is just a pipe dream.
Wow.. glad I chose not to invest in this
I would be careful not to defame his separate clinical practice. You'll be stuck defending a defamation claim and he'll use VDRM monies to go after you.
Just keep bashing your investment that's smart
Maybe posting Google Reviews to his clinic about his unethical business practices ?
I want the FULL capital loss, not this -30% crap hahahahaa
I imagine several complaints have already been filed or will be very soon.
IR has pretty much gone radio silent. Not one tweet or PR in nearly 4 months. No activity online about the company anywhere. Then otiko gives himself $700k loan with no explanation. IR guy gets a ton of shares for literally doing nothing.
It's obvious now that they did not ship any products in March either. Without any news or explanations that back into their previous PRs and tweets, lawsuits will be warranted against them. IMO.
Hopeful they have something big coming, but as each day passes it seems more unlikely.
Honestly I'd really like to file a complaint against him with the SEC or a private complaint but I'm not sure what that gets us. He doesn't have voting control of the company so the shareholders could call a meeting; we could probably fire him if we wanted to....but who would run the company? All I know is that our current President is self-dealing and substantially underperforming and something needs to happen or he will simply continue as he is.
The Doc is completely unchecked and accountable to no one. He is motivated by greed and his own self-interest and seemingly (despite the 100,000,000 share award to himself) has no interest in growing shareholder value. So long as the stock trades and he has shares to deal, he's happy (doesn't care about dilution).
Was literally thinking of that this morning. He won’t pump this for probably a year or two now. Hope he loses the $700K in Vegas this weekend
Also think we should seriously consider filing a complaint
come on Dr. hurry up and spend that $700K so ya can throw out another pump & fluff and move this crap along. we long time shareholders can use a little $cash$ also 🙂
Followers
|
617
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
74429
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
ViaDerma's proprietary transdermal delivery system allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy.
The technology allows transfer of chemicals through the stratum corneum (outer layer of skin) with a diffusion constant which is 10,000 times higher than the diffusion constant which characterizes water movement through the stratum corneum.
This enables ViaDerma to pair almost any active ingredient with the technology and provide rapid transport of the medicine right to the site of action.
The first product is a broad spectrum tetracycline-based topical antibiotic is the only antibiotic in the world that kills bacteria both a physical and a chemical mechanism. All known antibiotics (other than ours) primarily use only a chemical mechanism of kill. The physical mechanism of kill is a key feature of what we call Rapid Active Ingredient Delivery System (RAIDS). One result of RAIDS is that tetracycline is carried in higher concentrations, more quickly, to and through the cell walls, where the tetracycline can become more effective than if conventional antibiotics were used. Conventional antibiotics require more time (usually prescribed for 5 to 7 days for best results), whereas our tetracycline-based products usually produce desirable results in 24 hours (or less) because of the RAIDS effect.
A second important result of RAIDS is that the topical antibiotic kills all harmful Gram positive and Gram negative bacteria that have been available for testing. We believe this is the world’s strongest broad-spectrum topical antibiotic available.
The potential commercial impact is immense. Drug developers believe it takes much longer for bacteria to develop drug resistance to a physical kill mechanism. This is because it is relatively easy for bacteria to change their response to a chemical threat, but it takes numerous generations for bacteria to grow a new kind of cell wall structure to respond to a physical threat.
Our novel approach to overcome drug resistance of antibiotics is designed to sustain the effectiveness of antibiotics and other topical drugs for many years. This gives new topical drug products a longer useful lifetime and therefore more commercial value. This technology, when licensed to larger pharmaceutical companies, may provide stronger incentive for the discovery and development of new antimicrobial drugs. In recent years, the dearth of new antibiotics has been largely due to the uncertain new-drug commercial lifetime which is diminished when bacteria develop immunity to that drug.
In addition the technology can be licensed to other companies to convert existing oral drugs to transdermal medications extending the profitably of the existing drug.
We are developing products in the following fields of use;
Treats all types of bacteria including MRSA, VRE and other flesh eating bacteria. Fights drug resistant bacteria. $6B/year global market.
Onychomycosis, a fungal infection of the toenails, is a major health problem. It is estimated that there are in excess of 40 million sufferers with this condition in the USA. It is a problem throughout the world. A recent European study showed that the prevalence of Onychomycosis may be as high as 26.9%. Fungal resistance can occur when the oral antifungal agents are used on a long-term basis. Topically applied antifungal drugs may work somewhat better adjunctive to surgical removal or chemical dissolution of the nail plate. Yet, this often ineffective and traumatic procedure leaves the subject without a nail for months at risk for re-infection. Given the limitations of current treatment options in this $3B market, there is a great need for a simple, nontoxic and effective alternative treatment. Estimated Global prevalence rate: 140 million.
Treats symptoms of Influenza which is a$4B/ year global market: Common
Diabetic foot wounds.
Per 3/8/18 PR: ViaDerma’s technology is currently being used in Elixr Cannabis products; Topical Balm, Topical Serum and Topical Spray. Sales have begun in Canada.
Per 12/7/17 PR: The Company has signed an MOU and will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinary uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments.
Per 1/23/18 PR: The Company has also a licensing and distribution agreement in place with its Canadian partners to produce a CBD Topical Serum, which has a 92% absorption rate powered by ViaDerma's Patent Pending Dual Carrier Technology. The CBD and Terpene profile (enriched with specific essential oils and vitamins C, and D) is crafted to alleviate Chronic Dry Skin, Psoriasis, Eczema, Rosacea, and many other skin conditions. The serum has anti-inflammatory, anti-bacterial, and chronic pain relief properties that are absorbed by the skin and provide overall healing benefits. Sales are expected to begin in the first quarter of 2018 and are projected to generate approximately $2 million annual revenues.
The Patented Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.
CBD is a compound found in the Cannabis family of plants such as hemp. CBD is combined into our topical body care products like Elixr's Topical Balm, Serum, and Spray.
CBD is an antioxidant. Antioxidants protect our skin from damaging exposure to smoke, UV rays, and environmental pollutants. Cannabinoid receptors are located all throughout the skin, Topical CBD products interact with those receptors resulting homeostasis and healing. Studies show that CBD can help treat an array of skin conditions such as eczema, psoriasis, rosacea, and acne.
"What is Intellectual Property?" - A Publication by the World Intellectual Property Organization -
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |